Strata Skin Sciences, Inc. (NASDAQ:SSKN)‘s stock had its “buy” rating reiterated by equities researchers at HC Wainwright in a report issued on Thursday.

A number of other research firms also recently weighed in on SSKN. ValuEngine upgraded Strata Skin Sciences from a “strong sell” rating to a “sell” rating in a research report on Friday, September 1st. Rodman & Renshaw raised their price target on Strata Skin Sciences from $1.50 to $12.00 and gave the company a “buy” rating in a research report on Tuesday, May 16th. Finally, Zacks Investment Research downgraded Strata Skin Sciences from a “hold” rating to a “sell” rating in a research report on Wednesday, August 16th.

Strata Skin Sciences (NASDAQ:SSKN) opened at 1.71 on Thursday. The firm’s market cap is $4.24 million. Strata Skin Sciences has a one year low of $1.43 and a one year high of $5.40. The firm has a 50-day moving average price of $1.80 and a 200-day moving average price of $1.96.

Strata Skin Sciences (NASDAQ:SSKN) last released its quarterly earnings results on Thursday, August 10th. The medical device company reported ($0.52) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.71) by $0.19. Strata Skin Sciences had a negative return on equity of 41.58% and a negative net margin of 18.00%. The business had revenue of $8.70 million for the quarter, compared to the consensus estimate of $7.98 million. On average, equities analysts expect that Strata Skin Sciences will post ($3.14) EPS for the current fiscal year.

WARNING: “Strata Skin Sciences, Inc. (SSKN) Stock Rating Reaffirmed by HC Wainwright” was originally published by American Banking News and is the property of of American Banking News. If you are viewing this report on another website, it was illegally copied and republished in violation of U.S. and international copyright law. The original version of this report can be accessed at

About Strata Skin Sciences

STRATA Skin Sciences, Inc, formerly MELA Sciences, Inc, is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging.

Receive News & Ratings for Strata Skin Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Skin Sciences Inc. and related companies with's FREE daily email newsletter.